Search
Displaying all 9 results
Semaglutide
go.drugbank.com/drugs/DB13928
ApprovedInvestigational
Semaglutide is a glucagon-like peptide 1 (GLP-1) analog used to manage type 2 diabetes along with lifestyle changes, such as dietary restrictions and increased physical activity. Other members of this drug class include Exenatide and Liraglutide. Semaglutide was developed by Novo Nordisk and approved by the FDA for ...
Metabolic Dysfunction-associated Steatohepatitis (MASH)
go.drugbank.com/conditions/DBCOND0161012Nonfatal Myocardial Infarction
go.drugbank.com/conditions/DBCOND0052706End Stage Renal Disease (ESRD)
go.drugbank.com/conditions/DBCOND0035540Major Adverse Cardiovascular Events
go.drugbank.com/conditions/DBCOND0069054Cardiovascular Events
go.drugbank.com/conditions/DBCOND0048671Drugs: Acetylsalicylic acid · Amlodipine · Bisoprolol · Clopidogrel · Dalteparin · Lisinopril +9 moreCardiovascular Mortality
go.drugbank.com/conditions/DBCOND0040959Drugs: Acetylsalicylic acid · Canagliflozin · Colchicine · Dapagliflozin · Empagliflozin · Evolocumab +12 moreType 2 Diabetes
go.drugbank.com/conditions/DBCOND0030616